Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Sigita Liutkauskienė
Observed names:
Liutkauskienė, Sigita,
S. Liutkauskiene,
Sigita Liutkauskiene
Institutions:
Lithuanian University of Health Sciences,
Hospital of Lithuanian University of Health Sciences Kaunas Clinics
Observed institutions:
Lithuanian University of Health Sciences,
Hospital of Lithuanian University of Health Sciences Kaunas Clinics
ORCID:
0000-0002-4142-3136
Observed ORCID:
0000-0002-4142-3136
OpenAlex ID:
A5026434503
Retrospective analysis of the impact of anthracycline dose reduction and chemotherapy delays on the outcomes of early breast cancer molecular subtypes
2018
·
Sigita Liutkauskiene
, Saulius Grizas
, et al.
·
BMC Cancer
·
50
PDF
A randomized, double-blind, placebo-controlled phase II study of maintenance therapy with tasquinimod in patients with metastatic castration-resistant prostate cancer responsive to or stabilized during first-line docetaxel chemotherapy
2017
·
K. Fizazi
, A. Ulys
, et al.
·
Annals of Oncology
·
31
Retrospective analysis of the impact of platinum dose reduction and chemotherapy delays on the outcomes of stage III ovarian cancer patients
2015
·
Sigita Liutkauskiene
, Rasa Janciauskiene
, et al.
·
BMC Cancer
·
31
PDF
Health networking on cancer in the European Union: a ‘green paper’ by the EU Joint Action on Networks of Expertise (JANE)
2025
·
P.G. Casali
, H. Antoine-Poirel
, et al.
·
ESMO Open
·
16
PDF
Guidelines for diagnostics and treatment of aromatase inhibitor-induced bone loss in women with breast cancer
2014
·
Elona Juozaitytė
, Eduardas Aleknavičius
, et al.
·
Medicina
·
16
PDF
Sequential treatment of metastatic renal cell carcinoma patients after first-line vascular endothelial growth factor targeted therapy in a real-world setting: epidemiologic, noninterventional, retrospective–prospective cohort multicentre study
2023
·
Alvydas Cesas
, Vincas Urbonas
, et al.
·
Journal of Cancer Research and Clinical Oncology
·
7
PDF
An Open-Label Multicenter Safety, Tolerability, and Efficacy Study of Recombinant Granulocyte Colony-Stimulating Factor in the Prevention of Neutropenic Complications in Breast Cancer Patients
2011
·
Audrius Sveikata
, Sigita Liutkauskienė
, et al.
·
Medicina
·
5
PDF
A randomized, double-blind, placebo-controlled phase II study of maintenance therapy with tasquinimod (TASQ) in patients (pts) with mCRPC responsive to or stabilized during first-line docetaxel chemotherapy.
2016
·
Karim Fizazi
, Albertas Ulys
, et al.
·
Journal of Clinical Oncology
·
3
Complementary and alternative medicine remedies in the treatment of oncological patients – possible adverse effects and interactions with drugs: a literature review
2022
·
Jacevičiūtė, Emilija
, Minelgaitė, Rūta
, et al.
·
Medical Sciences
·
2
Onkologija ir hematologija : vadovėlis
2014
·
Dalia Adukauskienė
, Algidas Basevičius
, et al.
·
Lithuanian University of Health Sciences
·
2
37LBA Impact of p53 protein overexpression on survival of stage II young breast cancer patients
2009
·
S. Liutkauskiene
, E. Juozaityte
, et al.
·
European Journal of Cancer Supplements
·
2
Safety and efficacy study of the recombinant granulocyte colony-stimulating factor for prevention of neutropenia and neutropenia-related complications in women with metastatic breast cancer receiving docetaxel/doxorubicin
2009
·
Sigita Liutkauskienė
, Audrius Sveikata
, et al.
·
Medicina
·
2
PDF
Onkologija šeimos gydytojui. II dalis: klinikinė onkologija : vadovėlis
2008
·
Bierontienė, Danutė
, Griniūtė, Rasa
, et al.
·
Lithuanian University of Health Sciences
·
2
Genų, kurie koduoja estrogenų metabolizmą, polimorfizmų sąsajos su krūties vėžio rizika
2012
·
Aistė Savukaitytė
, Rasa Ugenskienė
, et al.
·
Lithuanian University of Health Sciences
·
1
Correlation between p53 protein expression and other molecular markers influencing the metastatic breast cancer outcomes
2011
·
Sigita Liutkauskienė
, Elona Juozaitytė
, et al.
·
The Breast
·
1
HER2 receptorių ir p53 baltymo padidėjusios raiškos įtaka II stadijos krūties vėžiu sergančių moterų gyvenimo trukmei
2010
·
Sigita Liutkauskienė
, Elona Juozaitytė
, et al.
·
Medicina
·
1
PDF
397P Primary resistance to the endocrine and CDK4/6 inhibitor therapy in postmenopausal women with metastatic breast cancer: An observational case-control study
2025
·
S. Liutkauskiene
, B. Brasiuniene
, et al.
·
ESMO Open
PDF
Correction: Sequential treatment of metastatic renal cell carcinoma patients after first-line vascular endothelial growth factor targeted therapy in a real-world setting: epidemiologic, noninterventional, retrospective–prospective cohort multicentre study
2025
·
Alvydas Cesas
, Vincas Urbonas
, et al.
·
Journal of Cancer Research and Clinical Oncology
A Study of Microenvironmental Factors Affecting the Metastasizing Potential of Ovarian Serous Carcinoma
2025
·
Morkūnaitė, Urtė
, Malonytė, Rasa
, et al.
·
Lithuanian University of Health Sciences
Impact of front-line platinum dose reduction on survival of advanced high-grade serous ovarian cancer with germline or somatic BRCA1/2 mutations
2024
·
Malonytė, Rasa
, Aleknavičienė, Kristina
, et al.
·
Lithuanian University of Health Sciences
Vėžys nėštumo laikotarpiu – šiuolaikinės diagnostikos ir gydymo rekomendacijos. Literatūros apžvalga
2023
·
Laura Liutkauskaitė
, Austėja Bingelytė
, et al.
·
Lithuanian General Practitioner
Survival Analysis of Patients Diagnosed With Metastatic Prostate Cancer in 2008-2016
2023
·
Sigita Liutkauskienė
, Roberta Žeimytė
, et al.
·
Health Sciences
PDF
Anemijos ir geležies nepakankamumo gydymas pacientams, kurie serga vėžiu. ESMO klinikinės praktikos gairės
2023
·
Austėja Bingelytė
, Laura Liutkauskaitė
, et al.
·
Lithuanian General Practitioner
Complementary cancer methods and evaluation of their efficiency: a literature review
2022
·
Liutkauskienė, Sigita
, Minelgaitė, Rūta
, et al.
·
Medical Sciences
Elektrochemoterapijos Veiksmingumas, Gydant Piktybinius Navikus: Literatūros Apžvalga Ir Klinikinis Atvejis
2021
·
Greta Chlebopaševienė
, Rasa Jančiauskienė
, et al.
·
Health Sciences
PDF
Show more works
View as search
Works count:
45
Citation count:
172
H-index:
6
I10-index:
5
Year
Topic
Type